Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome.
about
Treatment of primary Sjögren syndrome.Use of preservative-free hyaluronic acid (Hylabak(®)) for a range of patients with dry eye syndrome: experience in Russia.Clinical efficacy of a spray containing hyaluronic Acid and dexpanthenol after surgery in the nasal cavity (septoplasty, simple ethmoid sinus surgery, and turbinate surgery)Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK.Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial.Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eyeJBP485 promotes tear and mucin secretion in ocular surface epithelia.Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.Increased concentration of hyaluronan in tears after soaking contact lenses in Biotrue multipurpose solution.Topical Application of Apricot Kernel Extract Improves Dry Eye Symptoms in a Unilateral Exorbital Lacrimal Gland Excision Mouse.Pharmacotherapy of dry eye.Changing trends in the treatment of dry-eye disease.Recommendations for the treatment of Sjögren's syndrome.A randomised, crossover, multicentre study to compare the performance of 0.1% (w/v) sodium hyaluronate with 1.4% (w/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndrome.Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis.Investigating the potential benefits of a new artificial tear formulation combining two polymers.Enhanced corneal wound healing with hyaluronic acid and high-potassium artificial tears.Topical and systemic medications for the treatment of primary Sjögren's syndrome.Novel Artificial Tears Containing Cross-Linked Hyaluronic Acid: An In Vitro Re-Epithelialization Study.Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review.Hyaluronic Acid-Based Micelles as Ocular Platform to Modulate the Loading, Release, and Corneal Permeation of Corticosteroids.Optimising tear replacement rheology in canine keratoconjunctivitis sicca.
P2860
Q30249011-B1C6B68E-4248-4ECC-8F6C-79BFF2A62C01Q33800691-DBCCD24A-7683-45F7-8140-E515BA97E166Q33930494-7773D4D9-AF4E-4842-A54C-BDD9F49F1AB4Q35071714-A10B2607-ACDB-4B88-BE6E-AAB0B57547B4Q35507058-C11D576C-2FF5-41AE-99CA-6B40924BB853Q35589451-CD1698E8-59E2-45A0-8538-79118B657715Q35633676-464E6571-8F42-4DAF-953A-291C9BED809EQ35762862-B666A6C7-3089-456B-ACAB-2F66ACC78F2FQ37337974-95180B4A-EDC3-4886-BE81-D6EDF5B22A32Q37463430-0CAE65C0-3051-488E-966F-8E5C0D46E7ABQ37826752-1BBF6545-C483-42AE-B18F-AA74BB91D8A4Q38148616-BCA2E79D-4130-4770-961F-D556ABFA6CCFQ38584878-4194E284-3EF3-4C68-B5CC-FFADC80F62B1Q39403809-8195ECBC-80C8-4007-916D-5EE324849934Q41489266-1F222C3B-A651-434E-A14F-9692E7761B69Q41817907-CBE2BEA3-7F1D-4C2D-B6BE-151AF34C6323Q44146646-40EB5DA9-BCB2-436E-BF13-E3575B6EBF5FQ44498935-DB8F2293-AAA9-4B23-B25A-04B31F857521Q44877483-3889E371-D2C3-48B2-9B5C-467BBC7D6841Q47100458-52841F24-81A4-4DEE-BBF3-E810BECF4A2BQ49965212-DFA0C0AE-1DC4-40D1-A534-A63A9B4FF513Q50179475-12118518-4D2D-4392-989D-0BE4604D544E
P2860
Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Double blind, randomised, plac ...... treatment of dry eye syndrome.
@ast
Double blind, randomised, plac ...... treatment of dry eye syndrome.
@en
type
label
Double blind, randomised, plac ...... treatment of dry eye syndrome.
@ast
Double blind, randomised, plac ...... treatment of dry eye syndrome.
@en
prefLabel
Double blind, randomised, plac ...... treatment of dry eye syndrome.
@ast
Double blind, randomised, plac ...... treatment of dry eye syndrome.
@en
P2093
P2860
P356
P1476
Double blind, randomised, plac ...... treatment of dry eye syndrome.
@en
P2093
Mackintosh G
McDonald C
Prescott RJ
P2860
P304
P356
10.1136/BJO.83.10.1121
P407
P577
1999-10-01T00:00:00Z